ASP-0598

N/A

Report date: 2023/07/14 20:00:18

Base Information

Drug NameASP-0598
Drug Alias NameASP-0598
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionHeparin-binding EGF-like growth factor replacements
TargetsHeparin-binding EGF-like growth factor
Therapy Area/IndicationsTympanic Membrane Perforation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma IncAuration Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Global Development Inc
Active IndicationsN/A
Inactive IndicationsTympanic Membrane Perforation

Other Information

ATC CodeN/A
Related LinksN/A